In an attempt to close this gap, molecular docking was employed to assess potential antibacterial (anti-biofilm), anticancer (anti-inflammatory) and antiparasitic (anti-Leishmania) mechanisms using three putative target enzymes: the biofilm-associated Staphylococcus aureus sortase A (SaSrtA) (Thappeta et al., 2020), the inflammatory and cancer-associated human cyclooxygenase-2 (hCOX-2) (Méric et al., 2006) and the Leishmania infantum trypanothione reductase (LiTH) as an antiparasitic target (Saccoliti et al., 2017). Here, PTGS2 is linked to cancer.